Clinical Trial Update: The Effect of NK1R Antagonism on Alcohol Craving and PTSD Symptoms in Alcohol Dependent Patients With PTSD [Phase 2]

View source ↗

Summary

A Phase 2 trial tested NK1 receptor antagonism for reducing alcohol craving and PTSD symptoms in adults with alcohol use disorder and PTSD; results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Post-traumatic Stress Disorder

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcoholism, Alcohol Dependence | Phase 2 | Status: COMPLETED | Results posted: 2015-11-03